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Valorisation paragraph
This thesis focuses on the effects of nanomaterials after inhalation. In this paragraph, the 
value of this thesis for the society and economy is discussed.
In the society, there are concerns that nanotechnology poses risks to human and 
environmental health. For many people nanotechnology and related terms are difficult to 
understand as nanomaterials and nanotechnology cannot be seen by the naked eye. In the 
meantime, nanomaterials are used in a growing number of consumer products because of 
their unique physicochemical properties that are related to their small size. These unique 
properties can be beneficial - for example nanomaterials are used to develop efficient solar 
cells, dirt-repellent textiles, anti-cancer drugs and fast computers - or they might introduce 
health risks. There is need for adequate and efficient risk assessment of nanomaterials 
to keep up with the growing number of products containing nanomaterials. Currently, 
there are 292 personal care products on the market that claim to contain nanomaterials 
(Nanotechnologies, 2014). People can be exposed to these products daily, while the safety 
of these nanomaterial containing products is not tested. There are many concerns in 
the society that a long-term exposure to nanomaterials will induce adverse effects in the 
future; we just do not know this yet. Especially inhalation of nanomaterials is of concern 
given the vulnerability of the lungs and the experiences in the past with asbestos. The 
challenge is to assure the safety of nanomaterials and nanotechnology without hampering 
the development of new products and services of which the society can benefit. 
At the moment, each nanomaterial with slightly different characteristics, e.g. 20 nm 
vs. 50 nm, spherical vs ellipses, coated vs. non-coated, should in principle be assessed 
separately. Given the large number and variety of nanomaterials, it is not feasible to 
test each nanomaterial with slightly different characteristics to identify their hazard. In 
this thesis, we identified the particle surface area that reaches the alveoli as a suitable 
dose descriptor to describe the acute effects of silver nanoparticles both after in vivo 
inhalation and in lung epithelial cells in vitro. The identified dose metric can be used 
in the risk assessment of silver nanoparticles to predict the acute effects of uncoated 
silver nanoparticles of different sizes that have not been tested yet, thereby reducing the 
number of studies needed to assess the risks of nanomaterials. For example the release 
of a pro-inflammatory cytokine in the lung fluid was increased by 20% after exposure 
to 1.7 x 109 nm2 silver nanoparticles per cm2 of alveoli, irrespective of the particle size. 
For 74 nm silver nanoparticles that not have been tested in our in vivo study, the release 
of this marker will probably also increase by 20% after exposure to 1.7 x 109 nm2 
silver nanoparticles per cm2 of alveoli. For the risk assessment of nanomaterials that 
differ in other characteristics like chemical composition, coating or surface charge, the 
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dose metric can be identified - in studies that test nanomaterials that vary in a single 
characteristic - to be able to predict the effects of other nanomaterials that not have 
been tested. In this way, information on the hazard of nanomaterials can be efficiently 
gathered without testing all nanomaterials separately. 
To perform risk assessment of nanomaterials without stopping innovation in the field of 
nanotechnology, there is need for new strategies that efficiently gather hazard information 
on nanomaterials. Next to this, a clear communication between industry, safety assessors 
and legislators is needed. Risk assessment of nanomaterials should not be based on a 
checklist of experiments that are required for other chemicals. Efforts should be made to 
optimize experiments for nanomaterials by focusing on nanomaterial characterization, 
dosimetry and the development of alternative methods. In order to make this work, 
industries should be transparent about the use of nanomaterials in products and possible 
exposure to both workers and consumers. In addition, safety assessors should be trained 
on nanomaterial characteristics and behaviour to be able to use this knowledge in the 
risk assessment of nanomaterials. Finally, legislators should be more flexible in accepting 
risk assessment information and strategies that are not based on checklists of (animal) 
experiments that are required for conventional chemicals. In this thesis, we present a 
new testing strategy to assess the acute effects of nanomaterials after inhalation without 
using animals. This testing strategy can help to speed up the risk assessment process and 
thereby the development of new nanomaterials and nanotechnology-enabled products. 
To inform people about the results of this thesis, many chapters are also presented in 
peer reviewed journals, at conferences and in a short movie. Peer reviewed journals are 
mostly read by colleagues within the nanotoxicology research field. At conferences, oral 
presentations and poster presentations reach a broader audience within the nanomaterial 
and toxicology field. Especially within NanoNextnl - which is a consortium of more 
than one hundred companies, universities, knowledge institutes and university medical 
centres, aimed at research into micro and nanotechnology - there was great interest in risk 
assessment of nanomaterials. NanoNextnl funds many phd projects that all are required to 
include risk assessment in their thesis. During a risk assessment and technology assessment 
(rata) course organized by NanoNextnl, the research present in this thesis was used 
to explain the importance of risk assessment of nanomaterials to other phd candidates 
that are involved in developing new nanomaterials and technologies. By including risk 
assessment in the development of nanomaterials and nanotechnology, products can be 
developed that are safe by design. This means that information on toxicity-determining 
characteristics of nanomaterials can be included in the development of new products. 
For example, the use of fibre shaped nanomaterials in sprays will be avoided as they are 
more hazardous compared to spherical particles. In addition, new nanomaterials can 
be tested in toxicity assays and subsequently modified until they induce minimal or no 
toxicity. NanoNextnl also encouraged collaboration between universities, institutes and 
industry resulting in sharing of knowledge between experts in the field of toxicology, 
risk assessment, physics, and chemistry. These collaborations will help future projects on 
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nanomaterials to include the expertise form different fields and will aid the development 
of nanomaterials that are safe by design. Next to this, the results of this thesis will be used 
as a case study in future workshops on dosimetry to inform other researchers about the 
importance to use the appropriate dose metric to describe the effects of nanomaterials. 
This thesis also resulted in a close collaboration with the Karlsruhe Institute of Technology 
(kit). The QualityNano (qNano) Transnational Access program of the qNano Research 
Infrastructure sponsored visits to kit. This gave us the opportunity to work with a newly 
developed exposure system that is able to expose cells in vitro to nanoparticles at the air-
liquid interface under temperature and humidity controlled circumstances. For studying 
the effects of nanomaterials after inhalation, such innovative systems are essential as they 
can mimic the in vivo inhalation more closely compared to conventional submerged 
exposures, especially regarding the deposited doses and dose rates. 
To inform the general public about research that is performed on the toxicity of 
nanomaterials after inhalation, a short movie was released via the website of the National 
institute for Public Health and the Environment (rivm):
http://www.rivm.nl/Documenten_en_publicaties/Algemeen_Actueel/Multimedia/
Infectieziekten/Wetenschapscommunicatie/Inademing_van_nanomaterialen/
Download/Inademing_van_nanomaterialen
This movie was specially made for the lay public as part of the project ‘Jonge onderzoekers 
in beeld’. The purpose of this project was to provide opportunity for phd students to 
present their research professionally and clearly to the general public, and to provide 
information to the public about the relevance to society of research conducted at the 
rivm. 
There are no specific regulatory frameworks or guidance documents for the risk 
assessment of nanomaterials (yet). In this thesis, a novel testing strategy is presented to 
assess the acute effects of nanomaterials after inhalation without using animals. If this 
testing strategy proves to be valid, a large number of nanomaterials can be tested. The 
testing strategy presented in this thesis focuses on the acute effects of nanomaterials after 
inhalation. A similar strategy can be designed for other exposure routes and effects, for 
example after oral exposure. By first determining the appropriate dose metric both in 
vivo and in vitro, preferably using available in vivo data, in vitro models can be validated. 
Next, these in vitro models can be used to determine the hazard of new nanomaterials 
after for example oral exposure. Information on the hazard of nanomaterials is essential 
for their risk assessment. In addition, the information can also be used to group 
nanomaterials by their hazard in order to find characteristics that are linked to hazard. 
This will help to develop and produce nanomaterials that are safe by design. This is 
beneficial to the economy as the development of nanomaterials and nanotechnology 
enabled products is a growing market. The society also benefits as safe nanomaterials 
can be used to develop beneficial products like sunscreens, medicines and computer 
technology while exposure to potentially harmful nanomaterials is minimized.
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